Back to Search Start Over

Development of a potent thrombin receptor ligand.

Authors :
Feng DM
Veber DF
Connolly TM
Condra C
Tang MJ
Nutt RF
Source :
Journal of medicinal chemistry [J Med Chem] 1995 Sep 29; Vol. 38 (20), pp. 4125-30.
Publication Year :
1995

Abstract

The N-terminal thrombin receptor peptide H-Ser-Phe-Leu-Leu-Arg-Asn-Pro-Asn-Asp-Lys-Tyr-Glu-Pro-Phe-OH (1) fully activates the thrombin receptor with an EC50 of 10 microM. Structural features in the tetradecapeptide which are responsible for receptor activation have been elucidated. Agonist potency has been enhanced 1000-fold with the design of the shortened peptide H-Ala-Phe(p-F)-Arg-Cha-HArg-Tyr-NH2 (56). This analog exhibits an EC50 of 0.01 microM and is the most potent agonist for receptor activation reported to date. The monoiodinated derivative H-Ala-Phe(p-F)-Arg-Cha-HArg-Tyr(3-I)-NH2 (59) exhibits an EC50 of 0.03 microM, a level sufficient for development of a radioligand.

Details

Language :
English
ISSN :
0022-2623
Volume :
38
Issue :
20
Database :
MEDLINE
Journal :
Journal of medicinal chemistry
Publication Type :
Academic Journal
Accession number :
7562949
Full Text :
https://doi.org/10.1021/jm00020a029